Bristol-Myers Squibb Co  $67.68

Bristol Myers Squibb Co. is a New York-based biopharmaceutical company engaged in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company's range of therapeutic classes includes oncology, immunology, cardiovascular, and fibrosis. Bristol Myers Squibb employs around 32,200 full-time employees. The firm's product line includes chemically synthesized or small molecule drugs as well as biologics produced from biological processes. Biologics are administered to patients through injections or infusion. Bristol Myers Squibb's biopharmaceutical products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude, and Breyanzi. To stay informed about Bristol Myers Squibb's performance, you may want to keep an eye on its share price, market cap, and stock price today. You can also check stocks share price today and premarket data. If you're interested in investing in Bristol Myers Squibb, you may also want to know the price of its shares in Malaysia. The company sells its products to a range of customers, including wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. Additionally, Bristol Myers Squibb has a pipeline of investigational medicines designed to target the common mutations associated with oncogenesis, including repotrectinib. So, the company's future prospects may impact its share price and stock price.